Battling HIV on Many Fronts

Abstract

After years of bad news, there is optimism in the battle against AIDS. In the United States, the number of deaths declined 19 percent in the first nine months of 1996 as compared with the same period in 1995 — from 37,900 to 30,700.¹ Among the many reasons are better medical care and better treatments for human immunodeficiency virus (HIV) infection and opportunistic infections.Two reports in this issue of the Journal provide compelling data on the benefits of a three-drug regimen consisting of a protease inhibitor and two nucleoside analogues. Hammer et al. studied 1156 patients with HIV infection, . . .